{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:43:17Z","timestamp":1780368197402,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.wneu.2021.07.018","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T05:02:43Z","timestamp":1625806963000},"page":"e292-e301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Final Outcome in Growth Hormone\u2013Secreting Adenomas After Combination of Maximal Tumor Resection and Medical Treatment"],"prefix":"10.1016","volume":"154","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8187-613X","authenticated-orcid":false,"given":"Alberto","family":"Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4700-9489","authenticated-orcid":false,"given":"Jose Luis","family":"Sanmillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7201-5808","authenticated-orcid":false,"given":"Andreu","family":"Gabarros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2021.07.018_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11102-012-0440-6","article-title":"Endoscopic endonasal approach for growth hormone secreting pituitary adenomas: outcomes in 53 patients using 2010 consensus criteria for remission","volume":"16","author":"Shin","year":"2013","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2021.07.018_bib2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10143-015-0613-7","article-title":"Endoscopic versus microscopic approach for surgical treatment of acromegaly","volume":"38","author":"Fathalla","year":"2015","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.wneu.2021.07.018_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/2010.7.FOCUS10167","article-title":"Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center","volume":"29","author":"Gondim","year":"2010","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.wneu.2021.07.018_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/2010.7.FOCUS10173","article-title":"Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas","volume":"29","author":"Hofstetter","year":"2010","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.wneu.2021.07.018_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/jc.2005-1208","article-title":"Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly","volume":"91","author":"Colao","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2021.07.018_bib6","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: An endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2021.07.018_bib7","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1365-2265.2007.03139.x","article-title":"Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide","volume":"68","author":"Karavitaki","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2021.07.018_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/eje.1.01824","article-title":"Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs","volume":"152","author":"Petrossians","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2021.07.018_bib9","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.wneu.2016.10.029","article-title":"Endoscopic endonasal versus microsurgical transsphenoidal approach for growth hormone-secreting pituitary adenomas\u2014systematic review and meta-analysis","volume":"97","author":"Phan","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.018_bib10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.wneu.2017.09.017","article-title":"Radiologic predictors for extent of resection in pituitary adenoma surgery. A single-center study","volume":"108","author":"Sanmill\u00e1n","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.018_bib11","first-page":"803","article-title":"Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification","volume":"122","author":"Micko","year":"2005","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.018_bib12","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1210\/jc.2009-2670","article-title":"A\u00a0consensus on criteria for cure of acromegaly","volume":"95","author":"Giustina","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2021.07.018_bib13","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1016\/j.wneu.2018.06.009","article-title":"Endoscopic endonasal approach to the growth hormone-secreting pituitary adenomas: Endocrinologic outcome in 68 patients","volume":"117","author":"Taghvaei","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.018_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.wneu.2017.08.182","article-title":"Endoscopic transsphenoidal approach for acromegaly with remission rates in 401 patients: 2010 consensus criteria","volume":"108","author":"Anik","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.018_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3340\/jkns.2009.45.5.271","article-title":"Surgical results of growth hormone-secreting pituitary adenoma","volume":"45","author":"Kim","year":"2009","journal-title":"J Korean Neurosurg Soc"},{"key":"10.1016\/j.wneu.2021.07.018_bib16","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00701-014-2098-5","article-title":"Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays","volume":"156","author":"Sarkar","year":"2014","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.wneu.2021.07.018_bib17","first-page":"906","article-title":"Endoscopic endonasal transsphenoidal treatment for acromegaly: 2010 consensus criteria for remission and predictors of outcomes","volume":"24","author":"Yildirim","year":"2014","journal-title":"Turk Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.018_bib18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3171\/2014.3.JNS132214","article-title":"Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.","volume":"121","author":"Nishioka","year":"2014","journal-title":"J Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.018_bib19","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3171\/2013.8.JNS13224","article-title":"Treatment of acromegaly by endo- scopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.","volume":"119","author":"Hazer","year":"2013","journal-title":"J Neurosurg"},{"key":"10.1016\/j.wneu.2021.07.018_bib20","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1210\/jc.2013-1036","article-title":"Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission.","volume":"98","author":"Starke","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2021.07.018_bib21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2265.2011.04193.x","article-title":"Acromegaly surgery in Manchester revisited: the impact of reducing surgeon numbers and the 2010 consensus guide- lines for disease remission.","volume":"76","author":"Wang","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2021.07.018_bib22","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1210\/jc.2011-0554","article-title":"Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome.","volume":"96","author":"Jane","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2021.07.018_bib23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/01616412.2017.1296653","article-title":"Efficacy of transsphenoidal surgery in achieving biochemical cure of growth hormone-secreting pituitary adenomas among patients with cavernous sinus invasion: a systematic review and meta-analysis","volume":"39","author":"Briceno","year":"2017","journal-title":"Neurol Res"},{"key":"10.1016\/j.wneu.2021.07.018_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11102-007-0002-5","article-title":"Treatment of acromegaly. Is there still a place for radiotherapy?","volume":"10","author":"Jallad","year":"2007","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2021.07.018_bib25","doi-asserted-by":"crossref","first-page":"386401","DOI":"10.1155\/2012\/386401","article-title":"Surgery and radiosurgery for acromegaly: a review of indications, operative techniques, outcomes, and complications","volume":"2012","author":"Marquez","year":"2012","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.wneu.2021.07.018_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2265.2003.01679.x","article-title":"Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly","volume":"58","author":"Beauregard","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2021.07.018_bib27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11102-013-0502-4","article-title":"Endoscopic endonasal approach for pituitary adenomas: a series of 555 patients","volume":"17","author":"Paluzzi","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2021.07.018_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2265.2012.04492.x","article-title":"Outcome of multimodal therapy in operated acromegalic patients, a study in 115 patients","volume":"78","author":"Albarel","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2021.07.018_bib29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/cen.12207","article-title":"Control of growth hormone and IGF1 in patients with acromegaly in the UK: Responses to medical treatment with somatostatin analogues and dopamine agonists","volume":"79","author":"Howlett","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2021.07.018_bib30","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1210\/jc.2013-3318","article-title":"Tumor shrinkage with lanreotide autogel 120 mg as primary therapy in acromegaly: results of a prospective multicenter clinical trial","volume":"99","author":"Caron","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2021.07.018_bib31","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1210\/jc.2013-2480","article-title":"Pasireotide versus octreotide in acromegaly: a head-to-head superiority study","volume":"99","author":"Colao","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2021.07.018_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11102-009-0191-1","article-title":"Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension","volume":"13","author":"Melmed","year":"2010","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2021.07.018_bib33","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1365-2265.2007.02825.x","article-title":"A\u00a0prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly","volume":"66","author":"Mercado","year":"2007","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875021010135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875021010135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:59:10Z","timestamp":1761814750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875021010135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":33,"alternative-id":["S1878875021010135"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2021.07.018","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Final Outcome in Growth Hormone\u2013Secreting Adenomas After Combination of Maximal Tumor Resection and Medical Treatment","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2021.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}